Friends! In this video, I'm going to do a Duolingo stock analysis & discuss the risks and upside potential of DUOL stock
1 extracted signal · 1 resolved · 0 still active
The Patient Investor11 Aug 2025, 22:31 UTC
AI-generated source summary
The video presents a fundamental analysis of Duolingo (DUOL) stock, initiated due to high investor demand. The company is described as a potential disruptor in the $500-700 billion education market, currently holding a $16 billion market cap. The analysis reviews Duolingo's Q2 2025 financial metrics, noting a 41% year-over-year revenue increase, an 84% increase in net income, and a 31% adjusted EBITDA margin. It's explained that Duolingo generates revenue primarily through converting monthly active users into paid subscribers and through advertising revenue, the MAUs are over 128 million while the paid subs are near 11 million, and the advertising revenue grows at 30% CAGR. The key metric discussed is the churn rate, benchmarked at 28% against competitors such as Babbel. A bullish long-term outlook is set, using earnings per share growth rate with 30x PE ratio over the next 5 years. Under the numbers the upside is 57%, this translates to a target of $582. Analysis is invalidated if the price is at $291 or lower.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Signals in this source
More Prediction Case Files from The Patient Investor
Why I Don't Own Google Stock & When I'm Buying
The CHEAPEST Quality Stock In The Stock Market!
Intuitive Surgical Stock Analysis! Risks & Upside Potential
There Is NO AI BUBBLE! I’m Buying Every Dip
2 Stocks I'm Buying In The Next 2 Weeks
Netflix Stock Is FINALLY A Buy!
The Patient Investor
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
